Clinical Trials Ontario Streamlined Research Ethics Review System Susan Marlin President and CEO CAREB NATIONAL MEETING 2015.

Slides:



Advertisements
Similar presentations
New Trials If you are seeking a collaboration with the UCL CCTU we require you to apply: At least 3 months before the application deadline By using the.
Advertisements

Bev White, Manager, Research Ethics Research Services, IWK Health Centre.
CAEP–State Partnerships: New Agreements, New Opportunities 2013 AACTE Annual Meeting Orlando, Florida Mark Lacelle-Peterson, CAEP Senior Vice President.
A Blueprint For Clinical Research: Standard Operating Procedures
Good Clinical Practice in Research
 The slides in this set are made available for use in presentations and educational sessions by health departments.  The information is provided for.
Multi-Institutional Facilitated IRB Review Philip A. Cola, MA Vice President, Research and Technology University Hospitals Case Medical Center Third Annual.
The IRB Process Tony Medure, M.A., CIP, RAC Vanderbilt Human Research Protection Program.
WHAT IS A RESEARCH ETHICS BOARD?
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
Managing Sponsorship Research Services University of Oxford.
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
WELCOME.. Foundations “Clinical trials save lives and improve quality of life for Canadians. Clinical trials are also an important economic engine for.
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
Building a Compliance Risk Monitoring Program HCCA Compliance Institute New OrleansApril 19, 2005 Lois Dehls Cornell, Esq. Assistant Vice President, Deputy.
National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) A single system for processing and reviewing applications.
Transitional Council of the College of Homeopaths of Ontario 1 Basil Ziv, Registrar May 2011 Road to the Regulation for Homeopaths in Ontario.
PHAB Slide Set 2013 The slides in this set are made available for use in presentations and educational sessions by health departments. The information.
Ontario Colleges Multi- college Ethics Review Process On behalf of the Multi-college ethics working group Lynda Atack, Centennial College Jill Dennis,
Central IRBs: Ceding IRB Oversight
Clinical Trials Ontario CTO Streamlined Research Ethics Review System Making Ontario a preferred location for global clinical trials, while maintaining.
CAREB ATLANTIC 2013 St. Thomas University and University of New Brunswick November 21st-22nd, 2013 Fredericton, NB Fredericton, NB.
Retha Britz Copyright 2013 All rights reserved for this presentation 1 Establishment and functioning of a REC Retha Britz.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
Clinical Trial Review and Approval: New Regulations and their implications Siddika Mithani, Ph.D Clinical Trials & Special Access Programme Therapeutic.
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
APGNS Continuing Professional Development & Competency Assurance Program (CPD) David C. Carter, P.Geo, FGC. November 13, 2013.
Framework for Regulation May Outline of Presentation 1.Background – Initiation of the Framework – Purpose of the Framework Framework Review.
GCP & ETHICS COMMITTEES Ravi Rengachari Vector Control Research Centre PONDICHERRY.
Cardiff and Vale UHB Bwrdd lechyd Prifysgol Caerdydd a’r Fro NHS R&D Overview How to avoid the common pitfalls? Thomas Fairman Research Liaison Manager.
VA Central IRB Annette R. Anderson, MS, RHIA, CIP VA Central IRB Administrator HRPP 101, September 2010.
The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.
IWK Research Ethics - Workshop Series Session #2 REB Review Procedures How to submit … October 24, 2013 Bev White, Manager, Research Ethics Research Services,
SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.
Clinical Trials Ontario Making Ontario a preferred location for global clinical trials, while maintaining the highest ethical standards Susan Marlin, President.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
THE NUTS AND BOLTS OF ADVISORY COMMITTEES Development of Work-Based Learning Programs Unit 6-- Developing and Maintaining Community and Business Partnerships.
The NCI Central IRB Initiative Third Annual Medical Research Summit Washington, D.C. March 2003.
Health Quality Ontario: Health System Performance New Zealand Master Class March 25, 2014.
Human Subjects Research Office of Responsible Research Practices Human Subjects Research Vanessa Hill, MSHS, CCRC Senior Quality Improvement Specialist.
VA Central IRB Annette R. Anderson, MS, RHIA, CIP VA Central IRB Administrator Local Accountability Meeting June 2011.
Systems Accreditation Berkeley County School District School Facilitator Training October 7, 2014 Dr. Rodney Thompson Superintendent.
Investigational Devices and Humanitarian Use Devices June 2007.
The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.
HRPP Policies & Forms Chapter Two Created/Revised for AAHRPP June 1, 2007.
Fully accredited since 2006 Tom Conquergood, CIP Working with Quorum October 13, 2015 Thomas Jefferson University.
Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
VA HRPP Accreditation October 18, 2011 Accreditation Conference Call PRIDE/Soundia Duche, MA, MS.
Open Public Meeting February 28, pm – 5 pm 1 Ashburton Place, Boston MassHealth Demonstration to Integrate Care for Dual Eligibles.
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.
Quality Metrics of Performance of Research Ethics Committees Cristina E. Torres, PhD FERCAP Coordinator.
GCP (GOOD CLINICAL PRACTISE)
Site Set-up and Conduct Caroline O’Leary and Carrie Bayliss.
Research and Development Dr Julie Hankin Medical Director.
Responsibilities of Sponsor, Investigator and Monitor
IRB Open House: Implementation of Single IRB Review
Remote Site Initiation Visits
COCE Institutional Review Board Academic Spotlight
Responsibilities of Sponsor, Investigator and Monitor
MAINTAINING THE INVESTIGATOR’S SITE FILE
Overview: IRBshare  IRBchoice
Ceding Review: Using the new SmartIRB Online Reliance System
CONDUCTING THE TRIAL AT
Introduction to TransCelerate
MAINTAINING THE INVESTIGATOR’S STUDY FILE
CTSA27 So you want COMIRB to be your sIRB: What you need to know.
Presentation transcript:

Clinical Trials Ontario Streamlined Research Ethics Review System Susan Marlin President and CEO CAREB NATIONAL MEETING 2015

ABOUT CLINICAL TRIALS ONTARIO  Clinical Trials Ontario is an independent not-for-profit organization  Established by the Province of Ontario in response to:  Significant decline in clinical research in Ontario  Recognition of:  research strengths (e.g. excellent research capacity, high quality data)  areas to improve (e.g. speed, cost)  Mandate for CTO Support a streamlined approach to conducting multi-centre clinical trials in Ontario while ensuring the highest ethical standards for patient safety  First priority – implementing a streamlined research ethics review system

CTO STREAM LAUNCHED: MARCH 4, 2015 New streamlined system for research ethics review launched in Ontario Press release posted on ctontario.ca  386 page views from Canada, UK, Japan, United States, Germany, India, Australia and Hong Kong. Stakeholder Pick-up  Life Sciences Ontario  Ontario SPOR SUPPORT Unit  CAHO Catalyst  CAREB  MEDEC

The System

CTO STREAMLINED RESEARCH ETHICS REVIEW SYSTEM  Supports a single REB in providing research ethics review and oversight to multiple research sites; relies on a “REB of Record Model”  REB oversight responsibilities delegated by participating institutions to the REB of Record  Can be used for any multi-site clinical research, i.e. industry sponsored or investigator initiated  Currently can accept multi-site clinical trials; in future multi-site health research will be accepted as well  Primary components:  CTO REB Qualification Program  CTO Stream: Web-based Research Ethics Review System  The Three P’s: Policies, Procedures & Paperwork

CTO REB QUALIFICATION PROGRAM  Provides REBs planning to participate in the CTO Streamlined Research Ethics Review System with an external review of their governance, membership, operations and review procedures.  Based on the Toronto Academic Health Sciences Network (TAHSN) qualification process.  REBs are reviewed against a transparent standard, the CTO REB Qualification Checklist, that is informed by the applicable regulations, policies and guidelines. REB Qualification Manual available at  CTO REB Qualification checklist aligned with the N2/CAREB REB SOPS.  Each full visit is conducted by a Qualification Team composed of:  Auditor with specific training relating to review of REBs  CTO Program Coordinator  Two experienced members from the research ethics community (e.g., REB Chair/Vice-Chair and REB Director/ Manager/ Coordinator) selected from the CTO College of Reviewers.

CTO REB QUALIFICATION PROGRAM  REB SOPs reviewed prior to on-site visit; on site interviews with REB Chair(s) & operations team and review of facilities and documentation.  Report issued following visit; all items (200+) must be addressed before “Qualification” status issued.  Qualification status remains in effect for 3 years with submission of annual updates.  8 REBs are CTO Qualified in Ontario; 2 in process; several others preparing;  Lessons learned:  Different ways to be compliant; documentation is key  Common issues/questions/concerns:  quorum, incidental findings, appeals, finding and maintaining REB members (e.g. law, community); staying on top of emerging issues and education  REB Council to be convened soon (goal: 10 REBs qualified); composed of REB Chairs and REB Operation Leads from each qualified REB.

CTO STREAM  Standalone web-based electronic platform:  Enables research ethics review, document management, and communication between multiple institutions and multiple REBs  Uses common application forms standardized for all types of clinical trials  Built on Infonetica platform  CTO Stream is built using the latest technology and is continuously being improved based on community feedback  Supports the latest version of the most popular browsers (Internet Explorer, Google Chrome, Firefox, Opera and Safari)  Supports all mobile platforms and tablets (Apple, Android and Blackberry)  Supports any file type for uploads (i.e., word documents, excel documents, pdfs and text files)  Built using smart questions and smart forms  Uses electronic signatures for all applications  User friendly easy to use environment with 24 hour support provided by CTO and Infonetica  Launched March 4, 2015 at the CTO Conference; studies going through system

Using the CTO Streamlined Research Ethics Review System

INSTITUTIONAL RESPONSIBILITIES Per TCPS2  Accountable for the research carried out in its own jurisdiction or under its auspices.  Responsible for the ethical acceptability and ethical conduct of research undertaken within its jurisdiction or under its auspices.  Establish or appoint REB(s) to review their research; can be an REB external to the institution; can establish/appoint one or more.  Grants the REB the mandate to review the ethical acceptability of research on behalf of the institution, including approving, rejecting, proposing modifications to, or terminating any proposed or ongoing research involving humans. (TCPS2 Article 6).  Delegation of research ethics review responsibilities to another REB requires a formal agreement. The REB is responsible for research ethics oversight, and protecting the rights, safety, and well-being of research participants (GCP and CGSB)

CTO PARTICIPATION AGREEMENT  Between CTO and Participating Institutions (e.g. academic hospital, community hospital, university)  Sets out CTO’s and the Participating Institution’s respective rights and obligations  Participating Institutions can serve as:  REB Host Institution: Institution has established an REB that is qualified (or to be qualified) by CTO and will serve as an REB of Record for multi-site clinical/health research  Recruiting Site: Investigators working under the auspices of the Institution will recruit participants to studies approved through the CTO System  Both  Includes as Schedule E the REB of Record Study Agreement, executed on a study-by-study basis  Parties to the agreement: REB Host Institution of the REB of Record, Institution of the Recruiting Site, and the Principal Investigator at the Recruiting Site.  Template agreement formally delegates REB review and oversight responsibilities to the REB of Record and must be executed prior to the start of the study at each Recruiting Site.

ASSIGNING THE REB OF RECORD  Industry Sponsored/Led Studies:  CTO will look first at matching the study area to REB expertise  If more than one qualified REB with expertise, will assign REB based on balancing workload of CTO studies amongst REBs  Investigator Led Studies:  Preference will be to assigning to the ‘home’ REB of the lead investigator; REB likely to have the expertise, and some desire expressed in the community for having more institutional support for Investigator led studies  If ‘home’ REB not possible, CTO will look to match REB expertise  If more than one qualified REB with expertise, will assign REB based on balancing workload of CTO studies amongst REBs

REB REVIEW FEES – INDUSTRY SPONSORED TRIALS  Industry Sponsor  Charged $3000 for each of the 1st 5 participating sites; $2000 for each of the next 5 and $1500 for each additional site after 10; $500 for the 4th and subsequent major amendments  REB of Record Institution  Receives $5000 for the initial review and $250 for each participating site after 2; $500 for the 4 th and subsequent major amendment  Recruiting Site Institution  Receives $500 per CTO trial they participate in, if they have an internal REB or support an institutional REB – allocated to support REB activities

JOINING THE CTO SYSTEM  Learn about the CTO System: CTO website, webinars, manuals + customized visits, presentations, webinars etc.  Understand and implement what policy, governance, procedural changes etc. need to implemented to use the system; all non-ethics local requirements for study initiation will need to be met  If your institutions intends to be a REB Host institution and is not qualified, prepare for REB Qualification (N2/CAREB SOPs)  Review and sign the CTO Participation Agreement  Customized training provided: REBs, investigators, institutional representatives

REB OF RECORD MODEL Initial Application Process REB application submitted by any registered investigator/site, i.e. “Provincial Applicant” CTO assigns REB of Record (any Qualified REB in Ontario) and advances application REB of Record reviews application and resolves any issues with applicant Once issues are resolved REB of Record approves study Recruiting Institution signs REB of Record Agreement, delegating ethics review and oversight to REB of Record; Local PI adopts approved consent form and submits site application focused on site specific information Site application advances to REB of Record REB of Record Host Institution signs REB of Record Agreement and REB reviews application (usually expedited) and resolves any issues with site applicant Step 1 Applying for a New Multi-Centre Clinical Trial Step 2 Adding New Investigators / Research Sites Sites wishing to participate are notified and given access to REB materials in CTO system REB of Record issues approval for site to participate

Continuing Oversight and Approval Documentation submitted by “Provincial Applicant” REB of Record reviews submission and resolves issues with provincial applicant Once issues are resolved, approval or acknowledgement is issued by REB of Record and sent simultaneously to all approved participating sites REB of Record reviews submission and resolves issues with research site Approval or acknowledgement issued by REB of Record New overall (study-level) event, e.g. amendment, Data Safety Monitoring Board report, safety update New site level event, e.g. continuing (annual) review, local Serious Adverse Event, protocol deviation Documentation submitted by research site REB OF RECORD MODEL

Building the System

LEARNING FROM WHAT HAS BEEN DONE Programs/Systems/Expert Papers etc. reviewed  Other programs for streamlining/harmonization – provincial, international  E-REB systems, locally and internationally  TAHSN REB System RFP  TAHSN REB Qualification Manual  AAHRPP accreditation process  Processes/policies etc. from multiple REBs  OCREB’s “Everything”, in detail  CIHR External Advisory Committee on Streamlining Health Research Ethics Review (SHRER)  Forms from multiple REBs  Consents from multiple REBs, groups etc.  CAREB guidance – e.g. SAEs  N2/CAREB REB SOPs

LEARNING FROM THOSE WHO DO IT

BUILDING TOGETHER  External Committees/Groups  REB Streamlining Working Group  Legal and Liabilities Working Group  IT and Metrics Working Group  Research Ethics Review Advisory Group  College of reviewers  Technical/Operations Committee  E-REB RFP Evaluation Committee  E-Forms Working Group (Clinical Trials)  Model Clinical Trials Agreement  Participant Engagement Advisory Group  Industry Advisory Group  CTO Participation Agreement Advisory Group  E-Forms Working Group (non-clinical trials) __________________________________________ Total = 109 Volunteers  Community Experts Hired PT/Seconded: 9  CTO In-house Team: 7

CTO 2015 CLINICAL TRIALS CONFERENCE

“TO DO LIST” Streamlined Research Ethics Review System  Initiate the CTO REB Council  Support multi-centre health research (non clinical trials)  Implement CTO Registry & Reporting capabilities  Develop template consent form (clinical trials)  Explore opportunities for provincial collaborations  Develop and offer CTO Stream for local REB review Other Streamlining Measures  Clinical Trial Agreements  Determine other opportunities for streamlining/efficiencies Participant/Public Engagement  Landscape review: Determine programs/areas where CTO can add value  Public / Participant surveys – partner with BCCRIN  Engage with health charities & patient advocacy groups  Develop participant & public facing materials for the website  Engage participant & public in program development where appropriate (e.g. sample consent forms)

CONTACT INFORMATION Website: @clinicaltrialON linkedin.com/company/clinical-trials-ontario Clinical Trials Ontario 661 University Avenue, Suite 460 MaRS Centre, West Tower Toronto, Ontario Canada M5G 1M1 Tel /